Similarly, in the Transwell experiment, in comparison with the normal control group, peptide ARHGEF9 significantly suppressed the invasion and migration of glioma cells (Figures 6(f)–6(i)). This evidence concerns the gene ARHGEF9 and central nervous system cancer.